Gastritis drug showdown: which version works better?
NCT ID NCT07385248
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study compares two versions of a drug for gastritis, a condition that causes stomach inflammation. Researchers will give 28 healthy adults both forms of the drug at different times to see which one is safer and how the body processes it. The goal is to gather information, not to treat the disease directly.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New gastritis drug candidate tested in three formulations to find the best acid controller
- New gastritis pill faces off against standard treatment in 470-Patient trial
- Simpler h. pylori treatment could reduce antibiotic use
- Gum bacteria linked to stomach troubles? small study investigates
- New hope for steroid users: drug may prevent stomach pain
- 120,000-Person study hopes to crack the code of chronic illness